Publications by authors named "Rodney Croos-Dabrera"

Claim this Profile
A
A plain language summary of the safety and effectiveness of isavuconazole for the treatment of serious fungal disease in children with a weakened immune system.
Antonio C Arrieta, Laura Kovanda, Marc Engelhardt, Mark Jones, Rodney Croos-Dabrera

Expert Rev Anti Infect Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial.
Heidi Segers, Jaime G Deville, William J Muller, Angela Manzanares, Amit Desai, Rodney Croos-Dabrera

Antimicrob Agents Chemother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.
George R Thompson, Julia Garcia-Diaz, Marisa H Miceli, M Hong Nguyen, Luis Ostrosky-Zeichner, Rodney Croos-Dabrera

Mycoses· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE).
Joshua Wolf, Krisztina Kalocsai, Claudia Fortuny, Stefan Lazar, Samantha Bosis, Rodney Croos-Dabrera

Clin Infect Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
Bart Jan Kullberg, Claudio Viscoli, Peter G Pappas, Jose Vazquez, Luis Ostrosky-Zeichner, Rodney Croos-Dabrera

Clin Infect Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole for treatment of rare invasive fungal diseases.
Oliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, Rochelle M Maher, Rodney Croos-Dabrera

Mycoses· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
John R Perfect, Oliver A Cornely, Markus Heep, Luis Ostrosky-Zeichner, Kathleen M Mullane, Rodney Croos-Dabrera

Mycoses· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Francisco M Marty, Oliver A Cornely, Kathleen M Mullane, Luis Ostrosky-Zeichner, Rochelle M Maher, Rodney Croos-Dabrera

Mycoses· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
Dimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, Oliver A Cornely, William Hope, Rodney Croos-Dabrera

J Antimicrob Chemother· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Mark H Wilcox, Kenneth J Tack, Emilio Bouza, Daniel L Herr, Bernhard R Ruf, Rodney V Croos-Dabrera

Clin Infect Dis· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Dong-Fang Lin, Ying-Yuan Zhang, Ju-Fang Wu, Fu Wang, Jing-Chuan Zheng, Rodney Victor Croos-Dabrera

Int J Antimicrob Agents· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Marin H Kollef, Jordi Rello, Sue K Cammarata, Rodney V Croos-Dabrera, Richard G Wunderink

Intensive Care Med· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Richard G Wunderink, Jordi Rello, Sue K Cammarata, Rodney V Croos-Dabrera, Marin H Kollef

Chest· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis